Research Article
Evaluation of IL-29 in Euthyroid Patients with Graves’ Orbitopathy: A Preliminary Study
Table 2
Clinical and biochemical characteristics of the study participants with Grave’s disease with Graves’ orbitopathy—GD with GO vs. participants with Graves’ disease without GO—GD without GO.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Data are presented in the form of number (%) or median (IQR). The italic values are those which are statistically significant. 1Chi-squared test with Yates’s correction; Mann–Whitney test in other cases, where it is not marked with the superscript one. ALT: alanine transaminase; AST: aspartate transaminase; FT3: free triiodothyronine; FT4: free thyroxine; hsCRP: high-sensitivity C-reactive protein; IQR: interquartile range; TGAb: antithyroglobulin antibodies; TPOAb: antithyroid peroxidase antibodies; TRAb: anti-TSH receptor antibodies; TSH: thyroid-stimulating hormone; U: unit; WBC: white blood cells. |